Magnetar Financial »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Magnetar Financial

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Magnetar Financial from 13F filings

Historical chart of Magnetar Financial investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Magnetar Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Magnetar Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $16M 16M 0.98
2023-12-31 $20M 21M 0.93

More positions owned by Magnetar Financial

Novartis Sponsored Adr (NVS)
Medtronic SHS (MDT)
Zimmer Holdings (ZBH)
Southwestern Energy Company (SWN)
Pioneer Natural Resources
Globus Med Cl A (GMED)
Westrock (WRK)
Churchill Capital Corp Vii Com Cl A (CVII)
M.D.C. Holdings
Juniper Networks (JNPR)
Albertsons Cos Common Stock (ACI)
Elanco Animal Health (ELAN)
McGrath Rent (MGRC)
Enerplus Corp
Axonics Modulation Technolog (AXNX)

View all positions for Magnetar Financial

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Lazard Asset Management
Millennium Management
BlackRock
Camden Asset Management
Advent Capital Management
Polar Securities
Bank of America Corporation
Magnetar Financial
State Street Corporation
CNH Partners
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1